+

NEWS & MEDIA

MEDIA CONTACT

Hilary Adams

TEL: (415) 889-1010

info@uscapitalpartners.com

US Capital Partners Provides $750,000 in Follow-On Financing for Advanced Health Sciences, Inc.

US Capital Partners, LLC has structured and put in place additional financing for an innovative and expanding Florida-based health care research and technology group.

SAN FRANCISCO, October 2013 – US Capital Partners, LLC has provided a $750,000 growth capital term loan for Advanced Health Sciences, Inc. (“AHS”), headquartered in West Palm Beach, FL. US Capital Partners is a private investment bank that makes direct debt investments, participates in debt facilities, and arranges equity placements for small to lower middle market companies.

“We are delighted that US Capital Partners has successfully provided this growth capital financing for us,” said Jeff Ramey, founder and CEO of AHS. “We returned to US Capital Partners following the successful financing of our sister company, Ramard, Inc. This new growth capital financing will allow AHS to offer a range of new cutting-edge natural health care products, including a varicose vein product, a migraine product, a respiratory product for sufferers of asthma and chronic obstructive pulmonary disease, and a digestive product to battle Celiac disease, Crohn’s disease, and diverticulitis.”

“In December 2012, US Capital Partners successfully provided an accounts receivable and inventory line of credit scalable to $1 million for AHS’s sister company, Ramard, Inc., an expanding developer of high-quality equine and canine nutraceutical health care products,” said Jeffrey Sweeney, CEO and Managing Director at US Capital Partners. “Ramard’s products are used by nine Olympics equestrian teams around the world, as well as top Kentucky Derby Thoroughbreds. We are delighted now to have provided $750,000 in additional financing for the group.”

About Advanced Health Sciences, Inc.

AHS is a collaboration of experienced health care professionals and scientific specialists who are dedicated to developing innovative, next-generation products for specific targeted health concerns. The company’s team of researchers, biochemists, and molecular biologists are on the cutting edge of research and technology to provide a focused approach to health and well-being. AHS products are manufactured in an FDA and cGMP (current Good Manufacturing Practices) facility in the United States to ensure outstanding quality.

About US Capital Partners, LLC

Since 1998, US Capital Partners (www.uscapitalpartners.net) has been providing prompt, innovative, and reliable financing solutions including lending, equity financing, and debt re-structuring to businesses across the United States and abroad. US Capital Partners is a private investment bank, direct lender, co-lender, and lead financial arranger that specializes in asset-based debt for small to middle market private and public companies. The company’s innovative approach allows it to provide the best financing available, not only for companies in excellent financial condition, but also for companies that may have been refused credit by traditional lenders.

To learn more about how your business can secure the investment banking services it needs, email Jeffrey Sweeney, CEO and Managing Director, at jsweeney@uscapitalpartners.net or call (415) 889-1010.

Download a PDF of this Press Release

top